2014
DOI: 10.3899/jrheum.130847
|View full text |Cite
|
Sign up to set email alerts
|

Colchicine in Behçet Syndrome: A Longterm Survey of Patients in a Controlled Trial

Abstract: Continuous use of colchicine, even when initiated at an early disease stage, does not seem to decrease the use of immunosuppressives in the long term.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
9
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 19 publications
(11 citation statements)
references
References 11 publications
2
9
0
Order By: Relevance
“…In our study, the number of OU during the last three months was higher in patients who received mild therapies compared to in those who were treated with more intensive treatment choices. A less severe treatment protocol was especially associated with oral ulcer activity in female gender, explained by a milder disease course in them ( 17 , 23 ). Interestingly, the frequency of tooth brushing was also observed to be higher in females.…”
Section: Discussionmentioning
confidence: 99%
“…In our study, the number of OU during the last three months was higher in patients who received mild therapies compared to in those who were treated with more intensive treatment choices. A less severe treatment protocol was especially associated with oral ulcer activity in female gender, explained by a milder disease course in them ( 17 , 23 ). Interestingly, the frequency of tooth brushing was also observed to be higher in females.…”
Section: Discussionmentioning
confidence: 99%
“…Oral ulcer is the most common clinical manifestation of BD. In contrast to immunosuppressive agents, conventional treatments using topical medications and colchicine could not eliminate oral ulcer activity (13)(14)(15). Therefore, this condition may be a barrier to medication adherence in cases of mucocutaneous involvement.…”
Section: Introductionmentioning
confidence: 99%
“…9,10,12,36 These patients are not aggressively treated, as their manifestations do not have mortality risk and do not lead to permanent damage compared with those with major organ involvement. 3,10,[37][38][39] The effect of age on mucocutaneous manifestations was shown with two different analyses in our study. MI score was found to be high in younger female BS patients with systemic involvement.…”
Section: Discussionmentioning
confidence: 57%